De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Sharecare Beheer

Beheer criteriumcontroles 3/4

De CEO Sharecare's is Brent Layton, benoemd in Jan2024, heeft een ambtstermijn van minder dan een jaar. bezit rechtstreeks 0.39% van de aandelen van het bedrijf, ter waarde $ 2.07M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.7 jaar en 3.3 jaar.

Belangrijke informatie

Brent Layton

Algemeen directeur

US$235.0k

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	less than a year
Eigendom CEO	0.4%
Management gemiddelde ambtstermijn	3.7yrs
Gemiddelde ambtstermijn bestuur	3.3yrs

Recente managementupdates

Recent updates

Sharecare awarded three-year NCQA accreditation for wellness and health promotion

Sep 19

Sharecare Non-GAAP EPS of -$0.02 beats by $0.07, revenue of $103.8M beats by $0.87M

Aug 10

Analysts Have Lowered Expectations For Sharecare, Inc. (NASDAQ:SHCR) After Its Latest Results

Apr 03

Sharecare, Inc. (NASDAQ:SHCR) Analysts Just Slashed This Year's Estimates

Apr 02

Sharecare CEO Jeff Arnold - Healthcare Ripe For Disruption (Video)

Nov 23

CEO

Brent Layton (56 yo)

less than a year

Tenure

US$235,000

Compensatie

Mr. Brent Davis Layton serves as Director of Homeward Health Inc. since June 2023. He is Director at Sharecare, Inc. from January 11, 2023 and is its CEO since January 2, 2024. He was Senior Advisor to the...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Jeffrey Arnold	Founder & Executive Chairman	12.8yrs	US$18.19m	2.77% $ 14.6m
Brent Layton	CEO & Director	less than a year	US$235.00k	0.39% $ 2.1m
Dawn Whaley	President & Chief Marketing Officer	14.8yrs	US$7.28m	0.46% $ 2.4m
Justin Ferrero	President & CFO	14.8yrs	US$7.27m	0.44% $ 2.3m
Shannon Bagley	Chief Operating Officer	no data	geen gegevens	geen gegevens
Michael Blalock	Chief Accounting Officer & Principal Accounting Officer	2.8yrs	geen gegevens	0.043% $ 228.1k
Harsha Panyadahundi	Chief Technology Officer	2.3yrs	geen gegevens	geen gegevens
Walter De Brouwer	Chief Scientific Officer	3.7yrs	geen gegevens	geen gegevens
Colin Daniel	Chief Administrative Officer	2.8yrs	geen gegevens	0.13% $ 696.7k
Henry Jay	General Counsel & Diversity Officer	no data	geen gegevens	geen gegevens
Jen Hall	Executive Vice President of Corporate Communications	3.8yrs	geen gegevens	geen gegevens
Dermot Waters	Executive Vice President of Marketing	3.8yrs	geen gegevens	geen gegevens

3.7yrs

Gemiddelde duur

53.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van SHCR wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.7 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Jeffrey Arnold	Founder & Executive Chairman	12.8yrs	US$18.19m	2.77% $ 14.6m
Brent Layton	CEO & Director	1.8yrs	US$235.00k	0.39% $ 2.1m
Michael Roizen	Member of Advisory Board	no data	geen gegevens	geen gegevens
John Chadwick	Lead Independent Director	3.3yrs	US$290.00k	0.086% $ 451.6k
Jeffrey Allred	Independent Director	3.3yrs	US$252.54k	0.19% $ 1.0m
Vincent DeVita	Member of Advisory Board	no data	geen gegevens	geen gegevens
Tanya Altmann	Member of Advisory Board	no data	geen gegevens	geen gegevens
Barbara Ficarra	Member of Advisory Board	no data	geen gegevens	geen gegevens
Arthur Crowley	Member of Advisory Board	no data	geen gegevens	geen gegevens
David Demartini	Member of Advisory Board	no data	geen gegevens	geen gegevens
Patricia Geraghty	Member of Advisory Board	no data	geen gegevens	geen gegevens
Sandro Galea	Independent Director	3.3yrs	US$253.23k	0.038% $ 198.8k

3.3yrs

Gemiddelde duur

56yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van SHCR wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.3 jaar).

Sharecare Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

Founder & Executive Chairman exercised options and sold US$245k worth of stock

Chief Administrative Officer recently sold US$154k worth of stock

President & CFO notifies of intention to sell stock

Sharecare, Inc., Annual General Meeting, Jun 13, 2024

Sharecare, Inc Appoints Nicole Torraco to its Board of Directors

Founder & Executive Chairman exercised options and sold US$216k worth of stock

Recent updates

Founder & Executive Chairman exercised options and sold US$245k worth of stock

Chief Administrative Officer recently sold US$154k worth of stock

President & CFO notifies of intention to sell stock

New minor risk - Shareholder dilution

Altaris, LLC entered into a definitive agreement to acquire Sharecare, Inc. (NasdaqGS:SHCR) for approximately $520 million.

Price target decreased by 14% to US$1.50

Sharecare, Inc., Annual General Meeting, Jun 13, 2024

Sharecare, Inc. to Report Q1, 2024 Results on May 09, 2024

Rosen Law Firm Files A Class Action Lawsuit Against Sharecare Inc

Rosen Law Firm Files A Class Action Lawsuit Against Sharecare Inc

Sharecare Receives a Letter from the Listing Qualifications Department of the Nasdaq Stock Market

Sharecare, Inc Appoints Nicole Torraco to its Board of Directors

Sharecare, Inc. announced delayed annual 10-K filing

Sharecare, Inc. to Report Q4, 2023 Results on Mar 13, 2024

Founder & Executive Chairman exercised options and sold US$216k worth of stock

Founder & Executive Chairman exercised options and sold US$660k worth of stock

We Think Sharecare (NASDAQ:SHCR) Can Afford To Drive Business Growth

Price target decreased by 10.0% to US$3.00

Sharecare, Inc. Announces CEO Changes

Third quarter 2023 earnings released: US$0.07 loss per share (vs US$0.078 loss in 3Q 2022)

Sharecare, Inc. to Report Q3, 2023 Results on Nov 09, 2023

New minor risk - Share price stability

Consensus EPS estimates fall by 12%

We're Hopeful That Sharecare (NASDAQ:SHCR) Will Use Its Cash Wisely

Second quarter 2023 earnings: EPS misses analyst expectations

Sharecare, Inc. Provides Revenue Guidance for the Third Quarter Ending September 30, 2023 and Fiscal Year Ending December 31, 2023

Sharecare Expands Suite of Customer Activation and Management Solutions to Support Patient Education and Improve the Care Journey

Sharecare, Inc. to Report Q2, 2023 Results on Aug 09, 2023

There's No Escaping Sharecare, Inc.'s (NASDAQ:SHCR) Muted Revenues

Sharecare, Inc. (NasdaqGS:SHCR) announces an Equity Buyback for $50 million worth of its shares.

Consensus EPS estimates fall by 16%

Consensus EPS estimates fall by 61%

Sharecare, Inc. Revises Revenue Guidance for the Fiscal Year Ending December 31, 2023

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Key Executive exercised options and sold US$94k worth of stock

Full year 2022 earnings: EPS misses analyst expectations

We Think Sharecare (NASDAQ:SHCR) Needs To Drive Business Growth Carefully

Sharecare Launches VR Program to Improve Well-Being of American Workforce and Bring Innovation to Exercise

Sharecare Launches Virtual Model of Its Medicare-Reimbursable Cardiac Rehabilitation Program, Ornish Lifestyle Medicine

Price target increased to US$3.50

Sharecare, Inc. Appoints Brent Layton to Its Board of Directors and Audit Committee

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Sharecare, Inc. to Report Q3, 2022 Results on Nov 10, 2022

Price target decreased to US$3.40

Sharecare Announces Nine New Digital Solutions Designed to Engage, Educate, and Support People in Managing Their Health

Sharecare Receives Three-Year NCQA Accreditation for Wellness and Health Promotion

Sharecare awarded three-year NCQA accreditation for wellness and health promotion

Sharecare Launches Self-Service Software Platform to Enable Independent Decentralized Clinical Research

Consensus EPS estimates fall by 69%

Second quarter 2022 earnings: EPS misses analyst expectations

Sharecare Non-GAAP EPS of -$0.02 beats by $0.07, revenue of $103.8M beats by $0.87M

Sharecare, Inc. to Report Q2, 2022 Results on Aug 10, 2022

Sharecare Names Harsha Panyadahundi Chief Technology Officer

Consensus forecasts updated

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Sharecare, Inc. (NasdaqGS:SHCR) announces an Equity Buyback for $50 million worth of its shares.

Sharecare Announces Sharecare+, its Whole Health, Payor-Agnostic Advocacy Solution

Price target decreased to US$6.67

Forecast breakeven date pushed back to 2023

Sharecare, Inc. to Report Q1, 2022 Results on May 12, 2022

Consensus revenue estimates fall by 12%

Analysts Have Lowered Expectations For Sharecare, Inc. (NASDAQ:SHCR) After Its Latest Results

Sharecare, Inc. (NASDAQ:SHCR) Analysts Just Slashed This Year's Estimates

Full year 2021 earnings: EPS misses analyst expectations

Sharecare, Inc. Provides Earning Guidance for the First Quarter Ending March 31, 2022 and Year Ending December 31, 2022

Sharecare, Inc. to Report Q4, 2021 Results on Mar 31, 2022

Price target decreased to US$10.50

Sharecare CEO Jeff Arnold - Healthcare Ripe For Disruption (Video)